Recent studies have identified prohibitin (PHB) as a key regulator of EMT and metastasis in bladder cancer through stabilization of β-catenin, thereby enhancing Wnt/β-catenin signaling. The gene discussed is PHB1; the disease is urinary bladder carcinoma.